To prevent the transmission of HBV and HCV and to reinforce the prevention of the transmission of viruses B and C during acts at risk - Burundi

ALHV logo

To prevent the transmission of HBV and HCV and to reinforce the prevention of the transmission of viruses B and C during acts at risk - Burundi

Virus
Hepatitis B
Hepatitis C
Type
Operational research
Technical assistance
Testing and treatment implementation
Setting
National
Other targets
HIV
Phase
Under consideration
Health outcomes
Incidence
Mortality
Prevalence
WHO region
African Region
Target goal
Country
Burundi
Key interventions
Community mobilization
Hepatitis B Vaccination
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Testing and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
Incarcerated populations (current and former)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Sexual contact(s)
Performance target
Blood safety
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Health outcomes additional info

Contribute to the elimination of viral hepatitis B and C viruses by 2030 as a serious threat to public health in Burundi.

Performance target additional info

  • Reduce new HBV and HCV infections by 30% by 2022
  • Reduce the prevalence of chronic HBV and HCV infections by 30% by 2022
  • Reduce mortality related to viral hepatitis by 10% by 2022

Summary and objectives

The core program of interventions and services for the prevention of viral hepatitis B and C includes basic interventions: immunization, particularly against hepatitis B virus; universal precautions and the safety of injections, products blood and surgical operations; prevention of mother-to-child transmission of hepatitis B virus; harm reduction services for people who inject drugs. Interventions to prevent the sexual transmission of hepatitis B and hepatitis C are important for some populations. Hepatitis prevention interventions also have broader positive health effects, for example prevention of HIV, sexually transmitted diseases and other blood-borne infections. To reduce the incidence of hepatitis, the aim is to raise awareness among the general public, but also and above all to reach out to the groups most at risk to reduce the risk of infections. An important part is devoted to training and education.

Last updated